2. PALLIATIVE AND END-OF-LIFE CARE PERSPECTIVES

Published on 09/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 09/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1301 times

CHAPTER 2. PALLIATIVE AND END-OF-LIFE CARE PERSPECTIVES
Mellar P. Davis and Kim K. Kuebler

CURRENT TRENDS

The April 21, 2005, cover story from USA Today touted that the “U.S. is getting old fast, seniors will out number school-age children in many states by 2030, the Census Bureau says in a report out today. That promises to intensify the political tug-of-war between young and old for scarce resources” (El Nasser, 2005). This article reviewed the recent population predictions by the U.S. Census Bureau that identified which states will have the largest elderly population growth over the next 25 years. “As you reach the end of life the last year or last two years—the use of medical care is very intense” (Cauchi, 2005, p. 3A). Most states are worried about access and utilization of state Medicaid funding as the Baby Boomers age and place more healthcare demands upon limited resources. Another front page article printed in the February 24, 2005 USA Today reported, “Health care tab ready to explode, costs could be 19% of total economy by 2014” (Appleby, 2005). Growth in healthcare spending will outpace economic growth through the next decade. By 2014, the nation’s spending for healthcare will equal $11,045 per person, up from $6,423 per person in 2005 (Appleby, 2005).
Yet another news release from June 15, 2005, reports that older Americans are less willing to sacrifice physician/hospital choice to save costs (Cassil, 2005). Elderly Americans are much less willing than are working-age Americans to limit their choice of physicians and hospitals to save on out-of-pocket medical costs (Cassil, 2005). The U.S. Department of Health and Human Services (DHHS) has projected that, by 2013, the enrollment share of Medicare managed care plans will increase by 30% from the current level of 12% (Cassil, 2005).
These newsworthy reports parallel the issues that will affect the care of patients living with chronic disease over the next several decades. By 2030, for the first time in history the old will outnumber the young; by 2010, the oldest of the Baby Boomers will reach the age of 65. Not only will there be an increase in older people, but also more people will be living longer with chronic disease (DHHS, 2002; Lynn & Adamson, 2003). Currently, the leading causes of death in the United States are cancer, heart disease, stroke, chronic obstructive pulmonary disease, and dementia (DHHS, 2002; Lynn & Adamson, 2003). Chronic diseases are symptomatic, are progressive, and can interfere with the patient’s functional ability and quality of life.
Because the majority of the palliative care programs have been initiated in the oncology setting, this has restricted palliative interventions into the management of chronic debilitating nonmalignant diseases (Kuebler, Lynn, & Von Rohen, 2005). Patients with other diseases such as heart failure and emphysema can also benefit by the knowledge and skills of the palliative care clinician and the comprehensiveness and reliability of palliative care programs (Kuebler et al., 2005). This chapter provides a historical overview of the field of palliative care. It briefly touches on the definitions associated with supportive, palliative, end-of-life, and hospice care. The advanced practice nurse (APN) providing services to the patient and family who are facing a limited prognosis is in an ideal position to apply the philosophy of palliative care to the care of the patient from diagnosis until death and to recognize when to consider supportive services such as hospice care.

DIFFERENTIAL TERMS AND HISTORICAL PERSPECTIVES

Preceding World War II, the specialty of oncology was divided into surgery, immunology, and endocrinology (Seymour, Clark, & Winslow, 2005). The majority of patients, however, often presented with advanced malignancy; the availability of palliative treatments within the traditional care system were rare, and prescribed opioids were limited for fear of hastening death, precipitating addiction, and producing euphoria (Seymour et al., 2005).
During this era, suffering at the end of life was perceived as a test of spiritual and psychological character. There were a few community-based studies during this time, highlighting the degree of suffering in individual patients. Despite patient suffering, the investigators did not recommend a change in policy or an evaluation of or change in practice patterns (Seymour et al., 2005). Some studies recommended that prescribers consider earlier use of opioids but do so with trepidation (Seymour et al., 2005). Peer reviewed papers found in medical publications during this time that documented the physical, mental, and emotional distress associated with dying generated limited, if any, medical interest in the care of the dying patient (Hinton, 1963).

History of Cancer Pain Management

The modern techniques to manage cancer pain were developed in the 1950s and 1960s and primarily focused on a biomedical approach versus the patient-centered holistic approach common today. The biomedical philosophy was based on the belief that there is a linear relationship between pain and the patient’s perception of his or her pain (Seymour et al., 2005). Pain was often viewed as an indicator of disease, and little attention was given to the patient’s complaint of pain and how it interfered with quality of life. Physicians focused on disease management as opposed to the patient’s perception of his or her symptoms (Seymour et al., 2005). Dr. Wall, a pioneer in the field of pain management, cleverly articulated the approach to symptom management during this time as the following: “In the course of this new direction, symptoms were placed on one side as a sign post along a highway which was driven towards the intended destination. Therapy directed at the sign post was denigrated and dismissed as merely symptomatic” (Wall, 1986, p. 1). Therefore, the frequent use of cordotomy, rhizotomy, and myelotomy was preferred and sought as a means of relieving pain, with opioids often held until the very end of life.

BEGINNING WINDS OF CHANGE

In 1958, Cicely Saunders from the United Kingdom and John Bonica from the United States simultaneously participated in separate prospective observational studies of patients living with and dying from advanced disease and their medical management. These investigators identified two common myths held by healthcare providers caring for this patient population regarding the management of cancer-related pain (Meldrum, 2005; Wall, 1997):
▪ Opioids are inevitably addicting.
▪ Opioids should be administered only with long dosing intervals.
Saunders and Bonica, however, regarded pain and suffering as an integral part of the daily responsibilities of the physician and nurses providing patient care. These pain management leaders took the initial and controversial stance that opioids were essential in the successful management of cancer-related pain (Meldrum, 2005; Seymour et al., 2005). Saunders’ first publication in 1958 outlined a philosophy of care that highlighted a holistic, multidimensional, patient-centered approach to pain and symptom management. This philosophy of care continues to provide the framework on which the hospice and palliative care movement is built. This care model includes the following key concepts (Seymour et al., 2005):
▪ The role of the physician should be to accompany the dying patient.
▪ All caregivers involved in the patient’s care should enter into and help to support the patient’s inner resources for his or her comfort.
▪ Physicians and nurses should apply the knowledge and science accumulated from evidence-based research and practice to provide relief and comfort for the dying patient and his or her family.

St. Christopher’s Hospice

Saunders’ initial work began at St. Joseph’s Hospice in London in 1958 and continued for 7 years. During this time, Saunders recorded detailed regimens of oral and regular opioid treatments, developed symptom management protocols when newly developed medications became available, listened and recorded conversations with patients, traveled, lectured, and authored extensively on the importance and value of opioid interventions in the management of cancer-related pain (Saunders, 2001). On one of her many trips to the United States, she became acquainted with Dr. Raymond Houde from Memorial Sloan-Kettering Cancer Institute in New York City. Houde had designed and participated in many clinical crossover trials involving various opioids in the management of cancer-related pain (Meldrum, 2005). Saunders embraced the value of rigorous research designs and positive clinical outcomes associated with research trials that could promote the selection and utilization of opioid medications in the management of patients with cancer pain. She then brought opioid research to St. Joseph’s Hospice and later to St. Christopher’s, both designated as demonstration sites. The positive research findings further confirmed Saunders’ assertions regarding the effective and safe use of routine opioids in the management of cancer-related pain (Meldrum, 2005).
The initial collaborative opioid studies took place between St. Christopher’s Hospice in the United Kingdom and Memorial Sloan-Kettering in the United States. Their combined published papers within the peer reviewed literature became the cornerstone in the foundation to the first World Health Organization (WHO) guidelines on cancer care management in 1982 (Meldrum, 2005).
This new approach to pain management through the utilization of opioids revealed that the methods used for pain control were simple and widely transferable from patient care settings, including the home environment (Saunders, 2001). St. Christopher’s became a preeminent clinically based, multidiscipline educational program. Clinicians often took sabbaticals at St. Christopher’s to become skilled and knowledgeable about the care and management of patients living with and dying from advanced malignancies. Many of the initial clinicians from St. Christopher’s took their newfound skills into the development of the earlier programs such as the Connecticut Hospice, Calvary Hospital, and the Royal Victoria Hospital in Montreal, Canada (Saunders, 2001).
St. Christopher’s Hospice, located in London, opened in 1967 with 54 patients, a 16-bed residential wing for the elderly, child care for the staffs’ children, a chapel for spiritual care, and planned bereavement services. Home care for home-bound patients began in 1969 and soon became the dominant focus of care (Saunders, 2001). As St. Christopher’s became recognized and sought after in the care of ill cancer patients, the inpatient-to-outpatient ratio became 1:10 (Saunders, 2001).

Palliative Medicine

The successful demonstration projects initiated at St. Joseph’s Hospice and St. Christopher’s led to the establishment of palliative medicine as a medical subspecialty in 1987. Practitioners in New Zealand, Australia, and the United Kingdom took the lead in establishing this medical specialty (Saunders, 2001). Palliative medicine today is a direct result of Saunders’ international travels, strong basic and clinical research studies, disseminated data, collaboration among multiple disciplines, and application of the reigning philosophy of “living until you die” (Saunders, 2001).
Saunders’ efforts, however, were not without several pitfalls that occurred along the road of hospice and palliative medicine development. The elitism, perfectionism, and protests from “conventional” care providers delayed and alienated important links to the palliative medicine movement (Saunders, 2001). The initial focus of palliative medicine was predominantly on cancer care, which further led to delays in accepting the challenges associated with other diseases such as human immunodeficient virus/acquired immunodeficiency syndrome (HIV/AIDS), chronic heart failure, chronic obstructive pulmonary disease, and amyotrophic lateral sclerosis. Today, however, these diseases have been integrated into the overview of palliative medicine.

CHALLENGES TO THE FUTURE OF PALLIATIVE MEDICINE

The ongoing reductionism and subspecialization that originates from Western medicine in the twenty-first century will challenge the ability to maintain the “whole person” concept of care. The explosion of HIV/AIDS in developing countries will prompt an urgent need to shorten the gap in basic palliative care between developed and developing countries (Saunders, 2001). There is a need to standardize palliative practices, and the routine utilization of psychometrically valid and reliable symptom assessment and quality of life instruments can help to identify outcomes for patients who receive palliative interventions. Palliative care clinicians could learn from Saunders’ original methods of listening, recording, observing, and measuring specific interventions. Palliative care clinicians should develop the skills and knowledge that are associated with appreciating and understanding the spiritual, social, and psychologic stress that patients experience with a life-limiting disease—and the impact that this has on the family or loved ones.

Current Palliative Care Trends

There is much activity to develop, validate, and promulgate symptom guidelines. This work is often derived from academic centers and transferred to community-based practices. However, these guidelines should be portable, simple, affordable, and effective. Palliative services should be considered as an extension of care to all patients with advanced disease and not reserved for the dying (Davis, Walsh, LeGrand et al., 2002). Palliation should begin prior to the end of life. This concept has been endorsed by the WHO revised definition of palliative care (Sepulveda et al., 2002): whereas palliative care
… is applicable early in the course of disease, in conjunction with other therapies that are intended to prolong life, such as chemotherapy or radiation therapy, and includes those investigations needed to better understand and manage distressing clinical complications (WHO, 2002).
Often, the aims that palliative care offer to the patient and family differ from the aims of treatment used in curative care (Widder & Glawisching-Goschnick, 2002). Clinicians, however, should consider integrating palliative interventions into the traditional disease-modifying plan of care. For example, discussions with the patient and his or her family that describe and discuss disease-modifying therapies should also include descriptions of and discussions on the integration of palliative interventions that can be used to improve the patient’s symptom profile and quality of life (Kuebler et al., 2005). Therefore, disease-modifying care (curative care) and palliative care can and should occur simultaneously and routinely. This allows clinicians to modify the course of disease management whenever possible by increasing the intensity of palliative interventions when the patient becomes symptomatic and all medical therapeutics in reversing underlying pathophysiology have been exhausted (Kuebler et al., 2005).

DEFINITION OF TERMS

Palliative care, supportive care, end-of-life, and hospice care are terms that are frequently used interchangeably. Yet, hospice and end-of-life care are distinctly different from the others. While hospice and end-of-life care are always a part of palliative care and/or supportive care, the reverse is not always true (Kuebler et al., 2005). The following discussion identifies the differences and similarities associated with these terms.

Supportive Care

The cure for cancer remains below 50% for all patients who present with cancer, and cancer accounts for more than 25% of all deaths in the United States (Browner & Carducci, 2005). Therefore, the evaluation and successful management of symptoms that accompany malignancy can help to define how well the patient lives with his or her disease (Cherny, Catane, & Kosmidis, 2003). Supportive care and its associated interventions are often used concurrently with traditional disease management to effectively manage the symptoms associated with a diagnosis of cancer or other advanced diseases (Cherny et al., 2003). Supportive care has been defined as optimizing comfort, improving function, maintaining social support, and minimizing the adverse effects of antitumor therapy during active cancer treatments (Cherny et al., 2003).
The National Institute for Clinical Excellence (NICE) guidelines in supportive and palliative care identified and described 13 characteristics associated with supportive care (Box 2-1). The rationale associated with defining these supportive care characteristics includes the following (Thomas & Richardson, 2004) points:
Box 2-1

1. Coordination of care
2. Patient views and values are ascertained during the development of supportive services
3. Face-to-face communication
4. Information that includes options at each pathway of care and free information services (verbal, written, or video) sensitive to culture, education, spiritual, and language needs
5. Psychological supportive services
6. Social supportive services
7. Spiritual supportive services
8. Palliative care services (general)
9. Specialists in palliative care services
10. Rehabilitation services
11. Complementary services
12. Social services for families and caregivers
Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here